These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11271403)

  • 1. Nicotine self-administration and withdrawal: modulation of anxiety in the social interaction test in rats.
    Irvine EE; Bagnalasta M; Marcon C; Motta C; Tessari M; File SE; Chiamulera C
    Psychopharmacology (Berl); 2001 Jan; 153(3):315-20. PubMed ID: 11271403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditioned anxiety to nicotine.
    File SE; Cheeta S; Irvine EE; Tucci S; Akthar M
    Psychopharmacology (Berl); 2002 Nov; 164(3):309-17. PubMed ID: 12424555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different treatment regimens and the development of tolerance to nicotine's anxiogenic effects.
    Irvine EE; Cheeta S; Marshall M; File SE
    Pharmacol Biochem Behav; 2001 Apr; 68(4):769-76. PubMed ID: 11526975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat.
    Paterson NE; Semenova S; Markou A
    Psychopharmacology (Berl); 2008 Jun; 198(3):351-62. PubMed ID: 18438738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dorsal raphé nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses.
    Cheeta S; Irvine EE; Kenny PJ; File SE
    Psychopharmacology (Berl); 2001 Apr; 155(1):78-85. PubMed ID: 11374339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine in alcohol deprivation increases alcohol operant self-administration during reinstatement.
    López-Moreno JA; Trigo-Díaz JM; Rodríguez de Fonseca F; González Cuevas G; Gómez de Heras R; Crespo Galán I; Navarro M
    Neuropharmacology; 2004 Dec; 47(7):1036-44. PubMed ID: 15555637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal.
    Irvine EE; Cheeta S; File SE
    Pharmacol Biochem Behav; 2001 Feb; 68(2):319-25. PubMed ID: 11267637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine.
    Irvine EE; Cheeta S; File SE
    Behav Pharmacol; 1999 Nov; 10(6-7):691-7. PubMed ID: 10780511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of administration of the nicotinic acetylcholine receptor antagonist BTMPS, during nicotine self-administration, on lever responding induced by context long after withdrawal.
    Hall BJ; Pearson LS; Buccafusco JJ
    Neuropharmacology; 2010 Feb; 58(2):429-35. PubMed ID: 19772864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescent nicotine exposure produces less affective measures of withdrawal relative to adult nicotine exposure in male rats.
    O'Dell LE; Torres OV; Natividad LA; Tejeda HA
    Neurotoxicol Teratol; 2007; 29(1):17-22. PubMed ID: 17184972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to passive nicotine vapor in male adolescent rats produces a withdrawal-like state and facilitates nicotine self-administration during adulthood.
    Kallupi M; de Guglielmo G; Larrosa E; George O
    Eur Neuropsychopharmacol; 2019 Nov; 29(11):1227-1234. PubMed ID: 31462388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study.
    Rahman S; Zhang J; Engleman EA; Corrigall WA
    Neuroscience; 2004; 129(2):415-24. PubMed ID: 15501598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent differences in nicotine reward and withdrawal in female mice.
    Kota D; Martin BR; Damaj MI
    Psychopharmacology (Berl); 2008 Jun; 198(2):201-10. PubMed ID: 18338157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of intravenously self-administered nicotine in rats.
    Lynch WJ; Carroll ME
    Exp Clin Psychopharmacol; 1999 Aug; 7(3):198-207. PubMed ID: 10472507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin releasing factor antagonist, alpha-helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned, anxiety.
    Tucci S; Cheeta S; Seth P; File SE
    Psychopharmacology (Berl); 2003 May; 167(3):251-6. PubMed ID: 12669178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to nicotine enhances its subsequent self-administration: contribution of nicotine-associated contextual stimuli.
    Neugebauer NM; Cortright JJ; Sampedro GR; Vezina P
    Behav Brain Res; 2014 Mar; 260():155-61. PubMed ID: 24295728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats.
    Levin ED; Rezvani AH; Xiao Y; Slade S; Cauley M; Wells C; Hampton D; Petro A; Rose JE; Brown ML; Paige MA; McDowell BE; Kellar KJ
    J Pharmacol Exp Ther; 2010 Mar; 332(3):933-9. PubMed ID: 20007754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats.
    Scuppa G; Cippitelli A; Toll L; Ciccocioppo R; Ubaldi M
    Drug Alcohol Depend; 2015 Nov; 156():126-132. PubMed ID: 26383997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Effects of Nicotine and Nicotine Withdrawal on Fear Conditioning in Male Rats.
    Robble MA; Holloway IL; Ridener E; Webber CJ; Caine SB; Meloni EG; Desai RI; Carlezon WA
    Int J Neuropsychopharmacol; 2020 Jul; 23(7):469-479. PubMed ID: 32242615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).
    Cohen C; Perrault G; Griebel G; Soubrié P
    Neuropsychopharmacology; 2005 Jan; 30(1):145-55. PubMed ID: 15292905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.